Back
Efficacy and Safety of Gefitinib or Platinum plus Taxane in Egfr-Mutant Advanced Non-Small Cell Lung Cancers: A Meta-Analysis of First-Line Randomized Controlled Trials
Adnan Aydiner
J. Cancer Ther. Vol.3 No.4, September 12, 2012  DOI: 10.4236/jct.2012.324060
       (PDF  248K)     HTML     
Better Selection Model for EML4-ALK Fusion Gene Test in Patients with Non-Small-Cell Lung Cancer
Dekel Shlomi, Amir Onn, Maya Gottfried, Jair Bar, Haim Biran, Maya Ilouze, Addie Dvir, Hovav Nechushtan, Lior Soussan-Gutman, Nir Peled
J. Cancer Ther. Vol.4 No.8, September 03, 2013  DOI: 10.4236/jct.2013.48A009
       (PDF  92K)     HTML     
Phase II Study of Carboplatin and Pemetrexed Followed by Gefitinib for Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive EGFR Mutation
Saki Manabe, Fumihiro Oshita, Shuji Murakami, Tetsuro Kondo, Haruhiro Saito, Takeshi Kaneko, Kouzo Yamada
J. Cancer Ther. Vol.6 No.15, December 14, 2015  DOI: 10.4236/jct.2015.615132
       (PDF  680K)     HTML      XML
The Impact of Chemotherapy on EGFR Mutation Status in Non-Small-Cell Lung Cancer: A Meta-Analysis
Xiaoshun Shi, Fuxi Huang, Allen M. Chen, Zhuolin Wu, Qianqian Huang, Ying Liang, Qipeng Zhou, Haiyun Mo, Xiaoxiang Li, Jiexia Zhang
Open J. Genet. Vol.7 No.4, December 21, 2017  DOI: 10.4236/ojgen.2017.74010
       (PDF  2512K)     HTML      XML
Behavior of circulating epithelial tumor cells (CETC) and FISH (fluorescence in situ hybridisation) of epidermal growth factor receptor (EGFR)-gene amplification in lung cancer patients during the course of therapy
May El Sherif, Claus Peter Schneider, Carola Rabenstein, Amina Hessein Hassab, Magdy Mamdouh El Bordiny, Mona Wagdy Ayad, Katharina Pachmann
Adv. Lung Cancer Vol.2 No.1, March 21, 2013  DOI: 10.4236/alc.2013.21001
       (PDF  451K)     HTML      XML
 
 
Top